Literature DB >> 8574588

Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.

Y Wu1, J Xu, S Shinde, I Grewal, T Henderson, R A Flavell, Y Liu.   

Abstract

BACKGROUND: T cells and B cells communicate by direct cell--cell interaction that is crucial to the functioning of the immune system. It is well established that the interaction between B-cell-expressed CD40 and T-cell-expressed CD40 ligand (CD40L) is critical for T-cell-dependent antibody responses, but the role of this interaction in T-cell responses is less clear. In this study, we have used mice with targeted mutations in the genes encoding CD40L or CD28 to investigate how the CD40-CD40L interaction induces on B cells a costimulatory activity that acts in addition to antigen to trigger T-cell growth.
RESULTS: We show that T cells from Cd40L-deficient mice induce a substantially reduced costimulatory activity on B cells compared to wild-type T cells, particularly at early time points. Surprisingly, T cells, from CD40L-deficient mice induce similar levels of B7-1 and B7-2 as do wild-type T cells. We further show that the CD40L-mediated induction of costimulatory activity precedes the induction of B7-1, B7-2 and the heat-stable antigen (HSA). CD4 T cells isolated from the CD28-deficient mice can receive costimulatory activity from CD40L-induced B cells, demonstrating that the induced molecules can costimulate T cells by a CD28-independent mechanism. We have generated a novel monoclonal antibody that inhibits the CD40L-induced costimulatory activity. Expression of the epitope detected by this monoclonal antibody correlates with the induction of the costimulatory activity, and the molecule recognized by the monoclonal antibody is a single chain of around 85 kDa, distinct from B7-1, B7-2, ICAM-1, ICAM-2, ICAM-3, HSA CD5, integrin and 4-1BB ligand.
CONCLUSIONS: Our results demonstrate that CD40L is both necessary and sufficient for rapid, T-cell-mediated induction of costimulatory activity on B cells. This costimulatory activity is distinct from B7-1 and B7-2, and is independent of CD28.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574588     DOI: 10.1016/s0960-9822(95)00257-0

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  7 in total

Review 1.  The CD40 ligand. At the center of the immune universe?

Authors:  I S Grewal; R A Flavell
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

2.  Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.

Authors:  Y Guo; Y Wu; S Shinde; M S Sy; A Aruffo; Y Liu
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

3.  Inhibition of the function of the FcgammaRIIB by a monoclonal antibody to thymic shared antigen-1, a Ly-6 family antigen.

Authors:  L Ding; E M Shevach
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

4.  Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction.

Authors:  G Carayanniotis; S R Masters; R J Noelle
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

5.  CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with histoplasma capsulatum.

Authors:  P Zhou; R A Seder
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

6.  CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.

Authors:  Y Wu; Y Guo; A Huang; P Zheng; Y Liu
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

Review 7.  Molecular basis and therapeutic implications of CD40/CD40L immune checkpoint.

Authors:  TingTing Tang; Xiang Cheng; Billy Truong; LiZhe Sun; XiaoFeng Yang; Hong Wang
Journal:  Pharmacol Ther       Date:  2020-10-20       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.